Past, present &future

2020

$10m Commercial and High Potency expansion.

Metrics adds three further high potency suites, for added flexibility to meet the demand for small and moderate commercial batch sizes.

2018

Commercial Manufacturing facility expansion complete.

Metrics Contract Services is now able to offer clients a comprehensive ‘concept to commercialization’ solution under one FDA site registration.

2015

$80m expansion to quadruple manufacturing capacity and grow development spaces.

Additional 126,000 sq. ft. facility to support and accelerate organic growth.

2012

Metrics Contract Services is acquired by Mayne Pharma. A transformational acquisition that materially enhances Mayne Pharma’s scale, market access, and capabilities and provides Metrics with a global footprint and expanded client resources.

2009

High Potency handling.

Metrics commissions dedicated high potent manufacturing facility.

2007

Quality and Commercial expansion.

Metrics opens commercial manufacturing and expand its quality control labs.

2000

Metrics opens current site at 1240 Sugg Parkway.

Adding GMP manufacturing suites and 50, 000 sq. ft. laboratory capacity.

1997

Product Development and Clinical Trial Supplies expansion.

Metrics expands its core service offering to support customers across the clinical journey.

1994

Metrics Contract Services founded.

Starting as a Contract Laboratory, Metrics’ rich analytical heritage begins.